New England Journal of Medicine · 2011 · 97 citations · 0 references
PharmacyPharmaceutical PolicyDrug LawPharmaceutical ManufacturingPharmaceutical RegulationDrug Shortage ManagementNew Drug ApplicationsPrescription Drug PolicyDrug Shortage EconomicsFda Drug RegulationFda RegulationGeneric Drug ApplicationsGeneric Drug Coverage IncentivesGeneric Prescribing IncentivesMedication ShortagesMedicine Shortages
To address the growing U.S. shortages of critical generic drugs, long-term remedies, both legislative and regulatory, must be considered. Some basic changes in generic-drug law and FDA practices and greater financial incentives for manufacturing generics may be key.